NCT05668754Phase 2Completed

Study of SDX in Patients With Idiopathic Hypersomnia (IH)

Study sponsor: Zevra Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2024-02-28Actual
Enrollment · participants66Actual
Source updated2026-06-30Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Actual enrollment decreased by 98 participants

− Before

164 participants (actual)

+ After

66 participants (actual)

Check registry source